Investment Process: -Build a portfolio of 10-15 high quality companies with a focus on long-term (decade+) durable growth -Focus on 3-5 of best industries for diversification. Also helps with biz cycles (Tech, Semis, Comm., Cons. Disc, Industrials, Finance, Healthcare good hist.)

$CFLT having itself a day! Software is back!

$SPGI Q4 '24: -Rev: $3.59B (+14% YoY) -EPS: $2.85 (+56% YoY), $3.77 Adj (+20% YoY) -NI: $880M (+52% YoY), $1.163B Adj (+18% YoY) -Op Margin: 36.5% (+8 pp), 46.7% Adj (+260 bps) -Ratings (+27% YoY), Indices (+21% YoY), Com Insights (+10% YoY) -$1.1B divis, $3.3B buyback in '24

Philly D just too much

Here we go

“There is nothing concealed that will not be disclosed, or hidden that will not be made known. What you have said in the dark will be heard in the daylight, and what you have whispered in the ear in the inner rooms will be proclaimed from the roofs.” Luke 12:2-3

$AMZN “Operating income reached $21.2B, up 61% YoY, marking our strongest quarter ever.” “We delivered over 9 billion items same or next day – a new record for Prime.” “Amazon’s ad business is now on a $69B annual run rate, more than double what it was four years ago.”

$AMZN '24 Q4 Earnings: -Revenue: $187.8B (beat $187.23B est) -EPS: $1.86 (beat $1.48 est) -AWS Revenue: $28.8B (+19% YoY) -Operating Income: $21.2B (vs. $13.2B in Q4 '23) -North America Revenue: $115.6B (+10% YoY) -International Revenue: $43.4B (+8% YoY, +9% FX-adjusted)

Compounders be compounding... $CSU.TO $CNSWF hitting all time high $TOI.V $TOITF edging closer to all time high Also on a roll acquisition wise in '25!

@investafter40 Amazes me how much is traded on these daily narratives

$GOOG Waymo "serving more than 4M pass trips...now avg over 150K trips each week and growing...Austin and Atl this year, Miami next year...Waymo One vehicles will arrive in Tokyo for their 1st intl road trip...also developing the 6th gen Waymo Driver, significantly lower HW costs"

$GOOGL dropping pledge to not use AI for weapons and surveillance systems:

$NOVO '24 Results: -Sales +26%, Op Profit +25% -N. America sales +30%, Intl sales +17% -Diab & obes care +26%, Wegovy +86% 👀 -R&D: CagriSema (22.7% WL), Semaglutide 7.2mg (20.7% WL) -Catalent acq done (3 sites) -'25 Outlook: Sales 16-24%, Op Profit 19-27% CER -Div per share +21%

$ODFL: -4Q rev down 7.3% amid soft US econ -Opr ratio +410bps 75.9% -LTL tons -8.2% (7.6% fewer shipmts, 0.7% less wt/shp) -LTL rev/100hw +3.8% excl fuel. -1Q divi now $0.28/share (+7.7% post 2‑for‑1 split) -Returned $967.3M of cash in buybacks in '24, 223.6M in dividends

@DurableCreators Yeah, Samsung has been a mess lately but I gotta think they eventually get it together. NVIDIA depends on all 3 players so I'm sure they will do all they can there. I'm planning to hold for 2-3 years and see where we are.

@DurableCreators Yeah, you could be right. I feel like the risk\reward is pretty good here though. They are well positioned for HBM and the AI transition should provide more pricing power. It's far more specialized than most people realize. MU also strategic for U.S.

$MSFT Q2: -Rev $69.6B vs $68.8B est -EPS $3.23 vs $3.13 est -Cloud ($40B) falls short of $41.1B target -Returned $9.7B to shareholders (divi + buybacks) Shares down ~3%

@davey_juice Yeah, if they aren't generating real cashflow I've resorted to trading them off their highs and lows. Definitely not where I feel safe parking large long term capital though.